Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 203

1.

The value of repeat Pap smear at the time of initial colposcopy.

Spitzer M, Ryskin M, Chernys AE, Shifrin A.

Gynecol Oncol. 1997 Oct;67(1):3-7.

PMID:
9345348
2.

The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears.

Recio FO, Sahai Srivastava BI, Wong C, Hempling RE, Eltabbakh GH, Piver MS.

Eur J Gynaecol Oncol. 1998;19(3):203-8.

PMID:
9641214
3.

Repeating cytology at initial colposcopy does not improve detection of high-grade abnormalities: a retrospective cohort study of 6595 women.

Rieck GC, Bhaumik J, Beer HR, Leeson SC.

Gynecol Oncol. 2006 May;101(2):228-33. Epub 2005 Dec 1.

PMID:
16325241
5.

A comparison of the reliability of repeat cervical smears and colposcopy in patients with abnormal cervical cytology.

Mayeaux EJ Jr, Harper MB, Abreo F, Pope JB, Phillips GS.

J Fam Pract. 1995 Jan;40(1):57-62.

PMID:
7807039
6.

Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?

Ferris DG, Wright TC Jr, Litaker MS, Richart RM, Lorincz AT, Sun XW, Borgatta L, Buck H, Kramer L, Rubin R.

J Fam Pract. 1998 Feb;46(2):125-34.

PMID:
9487318
7.

Clinical value of repeat Pap smear at the time of colposcopy.

Zardawi IM, Rode JW.

Acta Cytol. 2002 May-Jun;46(3):495-8.

PMID:
12040643
8.

Should the Pap smear be repeated at the first colposcopy visit?

Dolman G, Tan J, Quinn M.

Aust N Z J Obstet Gynaecol. 2005 Dec;45(6):514-7.

PMID:
16401219
9.

The value of cervical cytology in HIV-infected women.

Del Priore G, Maag T, Bhattacharya M, Garcia PM, Till M, Lurain JR.

Gynecol Oncol. 1995 Mar;56(3):395-8.

PMID:
7705674
10.

Appraisal of the modalities used to evaluate an initial abnormal Papanicolaou smear.

Higgins RV, Hall JB, McGee JA, Laurent S, Alvarez RD, Partridge EE.

Obstet Gynecol. 1994 Aug;84(2):174-8.

PMID:
8041525
11.

Managing atypical squamous cells of undetermined significance in Papanicolaou smears.

Morin C, Bairati I, Bouchard C, Fortier M, Roy M, Moore L, Meisels A.

J Reprod Med. 2001 Sep;46(9):799-805.

PMID:
11584480
12.

The borderline cervical smear: colposcopic and biopsy outcome.

al-Nafussi A, Rebello G, al-Yusif R, McGoogan E.

J Clin Pathol. 2000 Jun;53(6):439-44.

13.

Follow-up of abnormal Papanicolaou smears in a hospital-based adolescent clinic.

Lavin C, Goodman E, Perlman S, Kelly LS, Emans SJ.

J Pediatr Adolesc Gynecol. 1997 Aug;10(3):141-5.

PMID:
9288658
14.

Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.

Ciotti M, Sesti F, Paba P, Benedetto A, Patrizi L, Criscuolo A, Piccione E, Branca M, Syrjänen K, Favalli C.

Eur J Gynaecol Oncol. 2004;25(5):577-84.

PMID:
15493169
15.

Usefulness of concurrent Papanicolaou smear at time of cervical biopsy.

Panos JC, Jones BA, Mazzara PF.

Diagn Cytopathol. 2001 Oct;25(4):270-3.

PMID:
11599115
16.

Value of repeat cervical smears at the time of colposcopic biopsy.

Young NA, Naryshkin S, Bowman RL.

Diagn Cytopathol. 1993 Dec;9(6):646-9.

PMID:
8143537
17.

Biopsy correlates of abnormal cervical cytology classified using the Bethesda system.

Massad LS, Collins YC, Meyer PM.

Gynecol Oncol. 2001 Sep;82(3):516-22.

PMID:
11520149
18.

Comparison of repeat smear, colposcopy, and colposcopically directed biopsy in the evaluation of the mildly abnormal smear.

Maggi R, Zannoni E, Giorda G, Biraghi P, Sideri M.

Gynecol Oncol. 1989 Dec;35(3):294-6.

PMID:
2599462
20.

The effect of time interval between referral and colposcopy on detection of human papillomavirus DNA and on outcome of biopsy.

Berkova Z, Kaufmann RH, Unger ER, Reeves WC, Adam E.

Am J Obstet Gynecol. 2003 Apr;188(4):932-7.

PMID:
12712088

Supplemental Content

Support Center